诚达药业(301201.SZ)：股东前海晟泰拟减持不超过7.27%公司股份

Group 1 - The core point of the article is that Chengda Pharmaceutical (301201.SZ) announced that its shareholder, Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership), plans to reduce its holdings by up to 11,006,900 shares within three months after 15 trading days from the announcement date, which represents 7.27% of the total share capital excluding repurchased shares [1]